Report Description Table of Contents Industry Report and Statistics (Facts & Figures) - Sales Volume, ASP & Number of Procedure Conducted by Application & Procedure Type The global ligation devices market will witness a robust CAGR of 6.47%, valued at $992.94 million in 2021, expected to appreciate and reach $1745.69 million by 2030, confirms Strategic Market Research. Market Drivers One of the major factors driving the demand for ligation devices is the increasing preference for minimally invasive surgery. Ligation devices have played a significant role in the development of minimally invasive surgery (MIS) by enabling surgeons to seal blood vessels and tissues tightly during small incision surgeries, such as laparoscopic or robotic procedures. According to a 2021 article in the Surgical Clinics of North America, over 80% of typical procedures can be completed minimally invasively, underscoring the widespread use of MIS. Minimally invasive surgeries involve making smaller incisions, which are less invasive than open surgeries. This leads to reduced bleeding and tissue damage, resulting in quick recovery time & less discomfort for patients. Such procedures rely on ligation devices to provide accurate control over tissues and blood vessels in the smaller surgical field, reducing the chance of complications. Ligation devices help lower the incidence of problems like bleeding and infection. Their safe sealing of tissues and vessels reduces the possibility of bleeding after surgery, making the recuperation process easier for patients. Furthermore, fewer sutures may be required, minimizing the chance of surgical site infections. According to a 2017 study published in the Surgical Clinics of North America, compared to standard suturing procedures, the use of ligation devices during laparoscopic cholecystectomy (removal of the gallbladder) was associated with a much-decreased rate of bleeding problems. Due to the growing use of various innovative devices, methods, and treatment procedures like essure tubal ligation, adiana tubal occlusion, bilateral tubal ligation, intrauterine devices, contraceptive implants, postpartum tubal ligation, interval tubal ligation, bipolar coagulation, monopolar coagulation, tubal clipping, tubal ringing, uchida tubal ligation, adiana tubal ligation are propelling the growth of the market. Market Restraint The high cost associated with ligation devices may hinder their adoption in healthcare settings with limited resources. Although rare, ligation devices themselves can cause problems such as tissue injury after application or clip migration (movement after implantation). To ensure the highest level of safety and reduce these hazards, manufacturers must continuously allocate resources to research and development. Market Opportunity The demand for minimally invasive surgery is expanding in developing areas like Asia Pacific, and this, combined with expanding healthcare infrastructure, suggests that the ligation device market will see significant growth. As the surgical landscape changes, minimally invasive surgery, or MIS, is becoming increasingly popular in Asia Pacific. The fast-expanding senior population in this region is driving the need for less invasive surgical treatments, and ligation devices are ideal for this group because they are linked to shortened recovery periods and fewer complications. In addition, the importance of affordable healthcare solutions is increasing in Asia Pacific. Ligation devices have the potential to significantly reduce hospital stays and infection risks, which can save both patients and healthcare providers money. Market Analysis of Different Segments Covered in the Report By Product Accessories Handheld instruments By Procedure MIS Open Surgery By Application Gynecological Surgeries Gastrointestinal & Abdominal Surgeries Urological Surgeries Cardiovascular Surgeries Other Applications By End User Hospitals Other End Users By Region North America U.S. Canada Mexico Europe Germany France Italy Switzerland U.K. Rest of Europe Asia-Pacific Japan China India Rest of Asia-Pacific LAMEA Brazil Israel South Africa Saudi Arabia Rest of LAMEA Based on Product, the 'accessories market segment accounted for more than 55 percent of the market in 2020. It is predicted to expedite at a CAGR of 6.9% over the projected period. Accessories for ligation devices play a crucial role in improving the safety, functionality, and efficiency of ligation operations. Ligation devices are widely used in the medical field to perform various ligation operations, including both open and minimally invasive procedures, due to their flexibility and versatility. In 2020, the 'open surgery' segment accounted for a significant portion of the market for ligation devices, and it is predicted to continue to develop rapidly throughout the forecasted period. In open surgery, ligation devices provide a number of benefits over conventional suturing techniques, including quicker closure times, a lower chance of bleeding after surgery, and improved precision. Furthermore, ligation devices facilitate uniform and consistent closure, reducing the risk of problems and improving patient outcomes. In 2020, the 'gastrointestinal and abdominal surgeries' accounted for the most significant market share. Moreover, during the projected period, the cardiovascular surgeries sector is expected to drive the market expansion at a CAGR of 6.9%. Ligation devices play a crucial role in gastrointestinal and abdominal surgeries, particularly in minimally invasive techniques like laparoscopy. They seal tissues and control bleeding, improving surgical outcomes and patient safety. These instruments are designed to ligate tissues, ducts, and blood vessels, particularly during surgeries such as gastric bypass, cholecystectomy, appendectomy, and bowel resections. In 2020, the 'hospitals' segment held the largest ligation devices market share, with more than 75% of the entire market. Due to its advantages over conventional suturing techniques, ligation devices have become standard equipment in hospital settings, particularly for minimally invasive gastrointestinal and abdominal surgery. In 2020, North America dominated the ligation devices market because of increased healthcare costs and the prevalence of chronic conditions. The market for ligation devices in North America is experiencing growth primarily due to advancements in surgical techniques, an increase in the number of chronic conditions requiring surgical interventions, and greater demand for minimally invasive procedures. This growth is further fueled by the aging population, which is more susceptible to gastrointestinal and cardiovascular diseases. In addition, North America's expanding healthcare system and favorable reimbursement guidelines for surgical procedures have created a conducive market expansion environment. Ligation Devices Market Competitive Landscape Analysis Ethicon (Johnson and Johnson) ConMed Corporation Olympus Corporation Applied Medical B.Braun Melsungen AG Cooper Surgical Genicom Grena Think Medical Teleflex Incorporated Medtronic Ligation Devices Market Report Coverage Report Attribute Details Forecast Period 2021 - 2030 The market size value in 2021 USD 992.94 Million The revenue forecast in 2030 USD 1745.69 Million Growth rate CAGR of approximately 6.47% The base year for estimation 2021 Historical data 2017 – 2020 Unit USD Billion, CAGR (2021 - 2030) Segmentation By Product, By Procedure, By Application, By End-users, By Region By Procedure MIS, Open Surgery. By Product Accessories, Handheld instruments By Application Gynecological Surgeries, Gastrointestinal & Abdominal Surgeries, Cardiovascular Surgeries, Urological Surgeries, Other Applications By End User Hospitals, Other End Users By Region North America, Europe, Asia Pacific, LAMEA Country Scope United States of America, United Kingdom, Italy, Germany, France, Spain, Canada, China, India, Japan, Brazil, Argentina, Mexico, South Africa, Saudi Arabia, etc. Company Usability Profiles Ethicon, ConMed Corporation, Olympus Corporation, Applied Medical, B.Braun Melsungen AG, Cooper Surgical, Genicom, Grena Think Medical, Teleflex Incorporated, Medtronic. Recent Developments In June 2023, Biolitec recently revealed that it has added two more new advancements to its ELVeS Radial laser system, intended to be used for minimally invasive laser treatment of inadequate veins. The extra saline solution channel on the ELVeS Radial 2ring Pro laser fibre allows it to eliminate even the most convoluted veins. In November 2023, Phase Genomics, Inc., a leading company in providing genomic solutions, announced that they will present new data from the OncoTerra cytogenomics system, which uses proximity ligation sequencing, on the modern AVITI next-generation sequencing system. This platform is a revolutionary step towards quick risk stratification in acute myeloid leukaemia (AML) patients. Traditional cytogenetics assays like karyotyping, FISH, and CMA have identified large-scale structural changes in chromosomes to provide a thorough assessment. However, these assays often fail to identify clinically significant sub-microscopic changes, and their sequential approach can further delay the time it takes to obtain meaningful insight from sample collection. In November 2023, CooperCompanies acquired medical device assets from Cook Medical for over $300 million. The acquisition focuses mainly on the Doppler monitoring, obstetrics, and gynecology surgery industries. As part of the agreement, CooperCompanies paid $200 million at the time of the transaction, and the remaining $100 Mn will be paid in two yearly installments. The company has acquired a significant amount of Cook's minimally invasive medical devices for gynecological surgery, maternal fetal medicine, and Doppler monitor technology. This includes disposable equipment and accessories. Frequently Asked Question About This Report Who are the key players majorly operating in the market? The key players in the market are Ethicon (Johnson and Johnson), ConMed Corporation, Olympus Corporation, Applied Medical, B.Braun Melsungen AG, Cooper Surgical, Genicom, Grena Think Medical, Teleflex Incorporated, Medtronic. Which is the leading Product for the market? The accessories is the leading Product for the market. Which is the leading End- User for the market? The hospitals is the leading End- User for the market. Which region has the largest share in the market? The North American region has the largest share in the market. What is the ligation devices market growth? The global ligation devices market is expected to grow at a compound annual growth rate (CAGR) of 6.47% from 2021 to 2030 to reach USD 1745.69 Million by 2030. How big is this ligation devices market size ? The global ligation devices market size was $992.94 Mn in 2021 and is predicted to reach $1745.69 Mn by 2030, representing a CAGR of 6.47%. Sources https://ehnheart.org/publications-and-papers/publications/1202:heart-failure-and-cardiovascular-diseases.html https://cardiothoracicsurgery.biomedcentral.com/articles/10.1186/s13019-021-01556-1 https://www.cdc.gov/heartdisease/facts.htm https://www.cdc.gov/kidneydisease/publications-resources/ckd-national-facts.html 1. Introduction 1.1. Study Objective 1.2. Market Definition 1.3. Study Scope 1.3.1. Markets Covered 1.3.2. Geographic Scope 1.3.3. Years Considered 1.3.4. Stakeholders 2. Research Methodology 2.1. Data Procurement 2.2. Paid Database 2.2.1. Secondary Data 2.2.1.1. Key Secondary sources 2.2.2. Primary Data 2.2.2.1 Primary sources 2.2.2.2. Key industry insights 2.2.2.3. Primary interviews with experts 2.2.2.4. Key primary respondent list 2.3. Market Size Estimation 2.4. Bottom-Up and Top-Down Approaches 2.4.1. Bottom-Up Approach 2.4.1.1. Approach for arriving at market size by bottom-up analysis 2.4.2. Top-Down Approach 2.4.2.1. Approach for Capturing Market Size by Top-Down Analysis 2.5. Market Breakdown and Data Triangulation 2.6. Research Methodology 2.7. Risk Assessment 3. Executive Summary 3.1 Market: Post-Covid-19 3.1.1 Actual Scenario 3.1.2 Pessimistic Scenario 3.1.3 Optimistic Scenario 3.1.4 Market Summary 4. Industry Outlook 4.1 Market Snapshot 4.2 Global Ligation devices Market 4.2.1 Global Market, 2021 – 2030 (USD Million) 4.3 Regional Business Analysis 4.3.1 Global Market, by Region, 2021 - 2030 (USD Million) 4.4 By Product Business Analysis 4.4.1 Global Market, By Product Type, 2021 - 2030 (USD Million) 4.5 By Procedure Business Analysis 4.5.1 Global Market, By Procedure Type, 2021 - 2030 (USD Million) 4.6 By Application Business Analysis 4.6.1 Global Market, By Application Type, 2021 - 2030 (USD Million) 4.7 By End Product Business Analysis 4.7.1 Global Market, By End Product Type, 2021 - 2030 (USD Million) 4.8 Value Chain Analysis 4.9 Market Variable Analysis 4.9.1 Market Drivers Analysis 4.9.2 Market Restraints Analysis 4.10 Business Environment Analysis Tool 4.10.1 Market PEST analysis 4.10.2 Market Porter’s analysis 4.11 Penetration & Growth Prospect Mapping 5. Market Dynamics 5.1. Introduction 5.2. Market Dynamics 5.2.1. Drivers 5.2.2. Restraints 5.2.3. Opportunities 5.2.4. Challenges 5.3. Impact of Covid-19 On Market 5.4. Value Chain Analysis 5.5. Ecosystem 5.6. Patent Analysis 5.7. Trade Analysis 5.8. Tariff Analysis 5.9. Case Study Analysis 5.10. Porter’s Five Forces Analysis 5.10.1 Threat of New Entrants 5.10.2 Threat of Substitutes 5.10.3 Bargaining Power of Buyers 5.10.4 Bargaining Power of Suppliers 5.10.5 Degree of Competition 5.11. Procedure Analysis 5.11.1. Trends in Procedure (2014-2020) 5.11.2. Trends in Procedure (2021-2028) 5.12. Pricing Analysis 5.12.1. Average Price Trend Analysis (By region, By Countries) 6. Competitive & Vendor Landscape 6.1. Company Market Share Analysis 6.2. Manufacturers Ligation devices Manufacturing Sites, Area Served, Product Type 6.3. Market Competitive Situation and Trends 6.4. Manufacturers Mergers & Acquisitions, Expansion Plans 7. Global Market: By Product Type Segment Analysis 7.1. Introduction 7.2. Sales Volume & Revenue Analysis (2021-2030) 7.3. Handheld instruments 7.3.1. Handheld instruments market, 2021 - 2030 (USD Million) 7.4. Accessories 7.4.1. Accessories market, 2021 - 2030 (USD Million) 8. Global Market: By Procedure Segment Analysis 8.1. Introduction 8.2. Sales Volume & Revenue Analysis (2021-2030) 8.3. MIS 8.3.1. MIS market, 2021 - 2030 (USD Million) 8.4. Open Surgery 8.4.1. Open Surgery market, 2021 - 2030 (USD Million) 9. Global Market: By Application Segment Analysis 9.1. Introduction 9.2. Sales Volume & Revenue Analysis (2021-2030) 9.3. Gastrointestinal & Abdominal Surgeries 9.3.1. Gastrointestinal & Abdominal Surgeries market, 2021 - 2030 (USD Million) 9.4. Gynecological Surgeries 9.4.1. Gynecological Surgeries market, 2021 - 2030 (USD Million) 9.5 Cardiovascular Surgeries 9.5.1 Cardiovascular Surgeries market, 2021 - 2030 (USD Million) 9.6 Urological Surgeries 9.6.1 Urological Surgeries market, 2021 - 2030 (USD Million) 9.6 Other Applications 9.6.1 Other Applications market, 2021 - 2030 (USD Million) 10. Global Market: By End Product Segment Analysis 10.1. Introduction 10.2. Sales Volume & Revenue Analysis (2021-2030) 10.3. Hospitals 10.3.1. Hospitals market, 2021 - 2030 (USD Million) 10.4. Other End Users 10.4.1. Other End Usersmarket, 2021 - 2030 (USD Million) 11. Global Market: Regional Outlook 11.1 North America 11.1.1. North America Market, By End Product Type, 2021 - 2030 (USD Million) 11.1.4. North America Market, By Application, 2021 - 2030 (USD Million) 11.1.5. North America Market, by Country, 2021 - 2030 (USD Million) 11.1.4.1. U.S. 11.1.4.1.1. U.S. Market, By End Product Type, 2021 - 2030 (USD Million) 11.1.4.2. Canada 11.1.4.2.1. Canada Market, By End Product Type, 2021 - 2030 (USD Million) 11.1.4.2.2. Canada Market, By Region, 2021 - 2030 (USD Million) 11.1.4.2.3. Canada Market, by Applications, 2021 - 2030 (USD Million) 11.2. Europe 11.2.1. Europe Market, By End Product Type, 2021 - 2030 (USD Million) 11.2.2. Europe Market, by By Application, 2021 - 2030 (USD Million) 11.2.5. Europe Market, by country, 2021 - 2030 (USD Million) 11.2.4.1 U.K. 11.2.4.1.1. U.K. Market, By End Product Type, 2021 - 2030 (USD Million) 11.2.4.1.2. U.K. Market, By Applications, 2021 - 2030 (USD Million) 11.2.4.1.3. U.K. Market, by Region, 2021 - 2030 (USD Million) 11.2.4.2. Germany 11.2.4.2.1. Germany Market, By End Product Type, 2021 - 2030 (USD Million) 11.2.4.2.2. Germany Market, By Application, 2021 - 2030 (USD Million) 11.2.4.2.3. Germany Market, by Region, 2021 - 2030 (USD Million) 11.2.4.3. France 11.2.4.3.1. France Market, By End Product Type, 2021 - 2030 (USD Million) 11.2.4.3.2. France Market, By Region, 2021 - 2030 (USD Million) 11.2.4.3.3. France Market, by Application, 2021 - 2030 (USD Million) 11.2.4.4. Rest of Europe 11.2.4.4.1. Rest of Europe Market, By End Product Type, 2021 - 2030 (USD Million) 11.2.4.4.2. Rest of Europe Market, By Region, 2021 - 2030 (USD Million) 11.2.4.4.3. Rest of Europe Market, by Application, 2021 - 2030 (USD Million) 11.3. Asia Pacific 11.3.1. Asia Pacific Market, By End Product Type, 2021 - 2030 (USD Million) 11.3.2. Asia Pacific Market, By Application, 2021 - 2030 (USD Million) 11.3.5. Asia Pacific Market, by country, 2021 - 2030 (USD Million) 11.3.4.1. China 11.3.4.1.1. China Market, By End Product Type, 2021 - 2030 (USD Million) 11.3.4.1.2. China Market, By Region, 2021 - 2030 (USD Million) 11.3.4.1.3. China Market, by Application, 2021 - 2030 (USD Million) 11.3.4.2. India 11.3.4.2.1. India Market, By End Product Type, 2021 - 2030 (USD Million) 11.3.4.2.2. India Market, By Region, 2021 - 2030 (USD Million) 11.3.4.2.3. India Market, by Application, 2021 - 2030 (USD Million) 11.3.4.3. Japan 11.3.4.3.1. Japan Market, By End Product Type, 2021 - 2030 (USD Million) 11.3.4.3.3. Japan Market, by Application, 2021 - 2030 (USD Million) 11.3.4.4. South Korea 11.3.4.4.1. South Korea Market, By End Product Type, 2021 - 2030 (USD Million) 11.3.4.4.3. South Korea Market, by Application, 2021 - 2030 (USD Million) 11.3.4.5. Rest of ASIA PACIFIC 11.3.4.5.1. Rest of ASIA PACIFIC Market, By End Product Type, 2021 - 2030 (USD Million) 11.3.4.5.3. Rest of ASIA PACIFIC Market, by Application, 2021 - 2030 (USD Million) 11.4. Latin America 11.4.1. Latin America Market, By End Product Type, 2021 - 2030 (USD Million) 11.4.3. Latin America Market, by Application, 2021 - 2030 (USD Million) 11.4.4. Latin America Market, by country, 2021 - 2030 (USD Million) 11.4.4.1. Brazil 11.4.4.1.1. Brazil Market, By End Product Type, 2021 - 2030 (USD Million) 11.4.4.1.3. Brazil Market, by Application, 2021 - 2030 (USD Million) 11.4.4.2. Mexico 11.4.4.2.1. Mexico Market, By End Product Type, 2021 - 2030 (USD Million) 11.4.4.2.3. Mexico Market, by Application, 2021 - 2030 (USD Million) 11.4.4.3. Rest of the Latin America 11.4.4.3.1. Rest of the Latin America Market, By End Product Type, 2021 - 2030 (USD Million) 11.4.4.3.3. Rest of the Latin America Market, by Application, 2021 - 2030 (USD Million) 12. Competitive Landscape 12.1 Ethicon (Johnson and Johnson). 12.1.1. Company overview 12.1.2. Financial performance 12.1.3. Product Portfolio Analysis 12.1.4. Business Strategy & Recent Development 12.2. ConMed Corporation. 12.2.1. Company overview 12.2.2. Financial performance 12.2.3. Product Portfolio Analysis 12.2.4. Business Strategy & Recent Development 12.3. Olympus Corporation. 12.3.1. Company overview 12.3.2. Financial performance 12.3.3. Product Portfolio Analysis 12.3.4. Business Strategy & Recent Development 12.4. Applied Medical. 12.4.1. Company overview 12.4.2. Financial performance 12.4.3. Product Portfolio Analysis 12.4.4. Business Strategy & Recent Development 12.5. B.Braun Melsungen AG. 12.5.1. Company overview 12.5.2. Financial performance 12.5.3. Product Portfolio Analysis 12.5.4. Business Strategy & Recent Development 12.6. Cooper Surgical. 12.6.1. Company overview 12.6.2. Financial performance 12.6.3. Product Portfolio Analysis 12.6.4. Business Strategy & Recent Development 12.7. Genicom. 12.7.1. Company overview 12.7.2. Financial performance 12.7.3. Product Portfolio Analysis 12.7.4. Business Strategy & Recent Development 12.8. Grena Think Medical. 12.8.1. Company overview 12.8.2. Financial performance 12.8.3. Product Portfolio Analysis 12.8.4. Business Strategy & Recent Development 12.9. Teleflex Incorporated. 12.9.1. Company overview 12.9.2. Financial performance 12.9.3. Product Portfolio Analysis 12.9.4. Business Strategy & Recent Development 12.10. Medtronic. 12.10.1. Company overview 12.10.2. Financial performance 12.10.3. Product Portfolio Analysis 12.10.4. Business Strategy & Recent Development List of Tables (48 Tables) TABLE 1. Market, By Product Type, 2021-2030 (USD Million) TABLE 2. Market FOR Handheld instruments, BY REGION, 2021-2030 (USD Million) TABLE 3. Market FOR Accessories, BY REGION, 2021-2030 (USD Million) TABLE 4. Market, By Procedure, 2021-2030 (USD Million) TABLE 5. Market FOR MIS, BY REGION, 2021-2030 (USD Million) TABLE 6. Market FOR Open Surgery, BY REGION, 2021-2030 (USD Million) TABLE 7. Market, By Application Type, 2021-2030 (USD Million) TABLE 8. Market FOR Gastrointestinal & Abdominal Surgeries, BY REGION, 2021-2030 (USD Million) TABLE 9. Market FOR Gynecological Surgeries, BY REGION, 2021-2030 (USD Million) TABLE 10. Market FOR Cardiovascular Surgeries, BY REGION, 2021-2030 (USD Million) TABLE 11. Market FOR Urological Surgeries, BY REGION, 2021-2030 (USD Million) TABLE 12. Market FOR Other Applications, BY REGION, 2021-2030 (USD Million) TABLE 13. Market, By End Product Type, 2021-2030 (USD Million) TABLE 14. Market FOR Hospitals, BY REGION, 2021-2030 (USD Million) TABLE 15. Market FOR Other End Users, BY REGION, 2021-2030 (USD Million) TABLE 16. Market, BY REGION, 2021-2030 (USD Million) TABLE 17. NORTH AMERICA Market, BY COUNTRY, 2021-2030 (USD Million) TABLE 18. NORTH AMERICA Market, BY Applications, 2021-2030 (USD Million) TABLE 19. NORTH AMERICA Market, By End Product Type, 2021-2030 (USD Million) TABLE 20. NORTH AMERICA Market, BY APPLICATION, 2021-2030 (USD Million) TABLE 21. EUROPE Market, BY COUNTRY, 2021-2030 (USD Million) TABLE 22. EUROPE Market, By End Product Type, 2021-2030 (USD Million) TABLE 23. EUROPE Market, BY APPLICATION, 2021-2030 (USD Million) TABLE 24. ASIA-PACIFIC Market, BY COUNTRY, 2021-2030 (USD Million) TABLE 25. ASIA-PACIFIC Market, By End Product Type, 2021-2030 (USD Million) TABLE 26. ASIA-PACIFIC Market, BY APPLICATION, 2021-2030 (USD Million) TABLE 27. LAMEA Market, BY COUNTRY, 2021-2030 (USD Million) TABLE 28. LAMEA Market, By End Product Type, 2021-2030 (USD Million) TABLE 29. Ethicon (Johnson and Johnson): COMPANY SNAPSHOT TABLE 30. Ethicon (Johnson and Johnson): OPERATING SEGMENTS TABLE 31. ConMed Corporation: COMPANY SNAPSHOT TABLE 32. ConMed Corporation: OPERATING SEGMENTS TABLE 33. Olympus Corporation: COMPANY SNAPSHOT TABLE 34. Olympus Corporation: OPERATING SEGMENTS TABLE 35. Applied Medical: COMPANY SNAPSHOT TABLE 36. Applied Medical: OPERATING SEGMENTS TABLE 37. B.Braun Melsungen AG: COMPANY SNAPSHOT TABLE 38. B.Braun Melsungen AG: OPERATING SEGMENTS TABLE 39. Cooper Surgical: COMPANY SNAPSHOT TABLE 40. Cooper Surgical: OPERATING SEGMENTS TABLE 41. Genicom: COMPANY SNAPSHOT TABLE 42. Genicom: OPERATING SEGMENTS TABLE 43. Grena Think Medical: COMPANY SNAPSHOT TABLE 44. Grena Think Medical: OPERATING SEGMENTS TABLE 45. Teleflex Incorporated: COMPANY SNAPSHOT TABLE 46. Teleflex Incorporated: OPERATING SEGMENTS TABLE 47. Medtronic: COMPANY SNAPSHOT TABLE 48. Medtronic: OPERATING SEGMENTS List of Figures (24 Figures) Figure 1 Market: Research Methodology Steps Figure 2 Research Design Figure 3 Breakdown of Primaries: Market Figure 4 Research Methodology: Hypothesis Building Figure 5 Market: Application-Based Estimation Figure 6 Top 10 Companies with Highest No. Of Patent in Last 9 Years Figure 7 No. Of Patents Granted Per Year, 2019–2020 Figure 8 Import Data for Ligation devices, By Country, 2016–2020 (USD Thousand) Figure 9 Export Data for Ligation devices, By Country, 2016–2020 (USD Thousand) Figure 10 Data Triangulation Methodology Figure 11 Market, By Product, 2019 vs. 2025 (USD Million) Figure 12 Market, By Procedure, 2019 vs. 2025 (USD Million) Figure 13 Market, By End Product, 2019 vs. 2025 (USD Million) Figure 14 Market Share, By Application Type, 2019 vs. 2025 Figure 15 Geographical Snapshot of the Market Figure 16 Accessories to Witness Higher CAGR in Market for Product Segment during Forecast Period. Figure 17 Open Surgery to Witness Higher CAGR in Market for Procedure Type Segment during Forecast Period. Figure 18 Gastrointestinal & Abdominal Surgeries to Witness Higher CAGR in Market for Application Type Segment during Forecast Period. Figure 19 Hospitals to Witness Higher CAGR in Market for End Product Segment during Forecast Period. Figure 20 North America Accounted for the Largest Share of the Market, By Regional Basis, in 2019 Figure 21 Market: Drivers, Restraints, Opportunities, and Challenges Figure 22 North America: Market Snapshot Figure 23 Asia Pacific: Market Snapshot Figure 24 Vendor Dive: Evaluation Overview